FLOT vs CROSS Among Patients With Pathological Complete Response in Esophageal Adenocarcinoma

Study limitation reported by the research below: “This is a retrospective study; unmeasured confounders (e.g., tumor biology, surgeon volume, post-recurrence therapies) may explain part of the survival difference despite multivariable adjustment.”